Institut Català de la Salut
[Lau L] Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. [Baddour L] Departments of Medicine and Cardiovascular Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA. [Fernández Hidalgo N] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. [Brothers TD] Division of General Internal Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. Addiction Medicine Consult Service, Queen Elizabeth II Health Sciences Centre, Nova Scotia Health, Halifax, Nova Scotia, Canada. [Kong WKF] Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore. [Borger MA] Leipzig Heart Center, University of Leipzig, Leipzig, Germany
Vall d'Hebron Barcelona Hospital Campus
2025-07-08T10:57:40Z
2025-07-08T10:57:40Z
2025-06-21
Infective endocarditis; Multidisciplinary; Team
Endocarditis infecciosa; Multidisciplinari; Equip
Endocarditis infecciosa; Multidisciplinario; Equipo
Infective endocarditis (IE) is a relatively rare but life-threatening systemic infection, which remains associated with high morbidity and mortality. The epidemiology of IE has shifted to involve an increasing numbers of older patients with both cardiovascular and other types of prosthetic devices, multiple comorbid conditions often requiring invasive procedures, increasingly virulent pathogens, in particular Staphylococcus aureus, or that can harbour anti-microbial resistance, and an escalation of injection drug use in many areas of the world. In parallel, advancements in diagnostic and therapeutic options have led to complex strategies in patients’ management. Despite these epidemiologic shifts, clinical trials have been rare and most of the evidence guiding IE management derives from expert consensus or analysis of large registries. Because of this, a multi-disciplinary IE team-based approach has been recommended as the standard of care. The aim of this review is to explore the rationale for a multi-disciplinary team-based approach to the management of IE. This approach has proved to be potentially beneficial based on multiple investigations that have evaluated patient outcomes. In addition, implementation strategies, feasibility and options of the team approach have also been highlighted.
Article
Versió publicada
Anglès
Endocarditis bacteriana - Tractament; Medicaments antibacterians - Ús terapèutic; Infeccions per estafilococs - Tractament; DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Endocarditis, Bacterial; Other subheadings::Other subheadings::/therapy; DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Staphylococcal Infections; CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents; Other subheadings::Other subheadings::/therapeutic use; ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::endocarditis bacteriana; Otros calificadores::Otros calificadores::/terapia; ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas::infecciones estafilocócicas; COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos; Otros calificadores::Otros calificadores::/uso terapéutico
Oxford University Press
European Heart Journal;46(24)
https://doi.org/10.1093/eurheartj/ehaf219
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]